Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 20
Filter
Add more filters










Publication year range
1.
Environ Sci Technol ; 35(11): 2375-80, 2001 Jun 01.
Article in English | MEDLINE | ID: mdl-11414048

ABSTRACT

Quartz sandy soils from Simcoe, Ontario, Canada and North Carolina had sorption properties for chlorothalonil that were nearly the same. For labile surface sorption kinetics, the Simcoe soil gave a pseudo first-order rate constant of kS1 = (7.4 +/- 0.7) x 10(-2) days-1. At equilibrium, the labile surface sorption capacity theta c of Simcoe soil for chlorothalonil was 23.8 x 10(-6) (mol/g). The sorption properties of the 4-hydroxy derivative of chlorothalonil were different in two important respects. They were larger by an order of magnitude, and they were substantially different for the two soils. Sorption by the Simcoe soil was too fast for kinetics measurements by the on-line HPLC micro extraction method, but for the North Carolina soil kS1 = (1.15 +/- 0.01) days-1 was recorded. For the Simcoe and North Carolina soils, respectively, theta c > 200 (mumol/g) and theta c approximately 113 (mumol/g). Two conclusions can be drawn. First, the replacement of the Cl by OH on the 4 position of chlorothalonil makes the sorption effects much greater. Second, the stronger interactions are associated with a greater sensitivity to small differences in the chemical compositions of the soils. Subtle soil properties causing significant effects might include small amounts and physical structures of organic matter and metal oxides. This implies that, for predictive computer models, mechanism parameters will have to be correlated in two dimensions: chemical structure, and the composition and amounts of chemical materials in soils.


Subject(s)
Fungicides, Industrial/analysis , Nitriles/analysis , Quartz/chemistry , Soil Pollutants/analysis , Adsorption , Chemical Phenomena , Chemistry, Physical , Chromatography, High Pressure Liquid , Environmental Monitoring , Kinetics , Models, Theoretical , Sensitivity and Specificity , Silicon Dioxide
2.
Toxicol Lett ; 120(1-3): 317-21, 2001 Mar 31.
Article in English | MEDLINE | ID: mdl-11323190

ABSTRACT

The liver, which is the major organ responsible for the metabolism of drugs and toxic chemicals, is also the primary target organ for many toxic chemicals. Increasing evidence has indicated that inflammatory processes are intimately involved in chemical-induced hepatotoxic processes, and like other inflammatory diseases, such as autoimmunity, are responsible for producing mediators that can effect liver damage or repair. This review will summarize our current understanding of how inflammatory processes influence hepatic pathology and repair following exposure to established hepatotoxic chemicals including carbon tetrachloride, an industrial chemical, and acetaminophen, a widely used analgesic.


Subject(s)
Inflammation/physiopathology , Liver/drug effects , Animals , Humans , Mice , Proliferating Cell Nuclear Antigen/analysis , Receptors, Tumor Necrosis Factor/physiology , Tumor Necrosis Factor-alpha/physiology
3.
Brain Behav Immun ; 14(4): 288-304, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11120597

ABSTRACT

In this study, the hippocampal neurotoxicant trimethyltin (TMT) was used to examine possible differential susceptibility associated with the apolipoprotein E genotype. Mice-wild type (C57BL6J), APOE knockout, and APOE4 transgenic-received either saline or TMT (2 mg/kg, ip) at either 21 days or 8 months of age. At both ages, similar mRNA levels were seen in the hippocampus across genotypes for ICAM-1, A20, and MAC-1. GFAP mRNA was higher in the APOE knockouts and APOE4 as compared to wild-type mice. Within 24 h, TMT produced cell death of hippocampal dentate granule neurons and mild astrogliosis in all animals. In 21-day-old mice, TMT exposure significantly increased mRNA levels for ICAM-1 and MIP-1alpha in all genotypes. EB-22, GFAP, TNFalpha, and TGF-beta1 levels were significantly elevated in both wild-type and APOE knockout mice following TMT. At 8 months of age, genotype specific differences were observed. mRNA levels for GFAP, TNFbeta, TNFalpha, and MIP-1alpha were increased in both APOE knockout and APOE4 mice compared to wild-type mice. TMT exposure significantly increased mRNA levels for GFAP and MIP-1alpha in all animals. TNFalpha mRNA levels were increased in wild-type and APOE4 mice while EB22 mRNA levels were increased in both the APOE knockout and APOE4 mice but not wild-type mice. These data suggest an age-dependent effect on both microglia early inflammatory responses to injury associated with the APOE genotype.


Subject(s)
Aging/immunology , Apolipoproteins E/genetics , Apolipoproteins E/immunology , Cytokines/immunology , Hippocampus/immunology , Nerve Degeneration/immunology , Animals , Apolipoprotein E4 , Cell Death/immunology , Chemokine CCL3 , Chemokine CCL4 , Cytokines/genetics , Female , Gene Expression/immunology , Genotype , Glial Fibrillary Acidic Protein/genetics , Hippocampus/pathology , Intercellular Adhesion Molecule-1/genetics , Lymphotoxin-alpha/genetics , Lymphotoxin-alpha/immunology , Macrophage Inflammatory Proteins/genetics , Macrophage Inflammatory Proteins/immunology , Male , Mice , Mice, Inbred C57BL , Mice, Inbred DBA , Mice, Knockout , Nerve Degeneration/chemically induced , Nerve Degeneration/pathology , RNA, Messenger/analysis , Ribonucleases , Transforming Growth Factor beta/genetics , Transforming Growth Factor beta1 , Trimethyltin Compounds/toxicity , Tumor Necrosis Factor-alpha/genetics , Tumor Necrosis Factor-alpha/immunology , alpha 1-Antichymotrypsin/genetics
4.
Ann N Y Acad Sci ; 919: 214-20, 2000.
Article in English | MEDLINE | ID: mdl-11083111

ABSTRACT

Only recently have toxicologists come to understand the role of inflammation, and TNFalpha specifically, in classical toxicological processes. This relationship appears fairly complex, as inflammation and proliferation may well be only one facet of a time- and dose-dependent continuum of toxicological and repair processes. Not surprisingly, considerable efforts are being undertaken using our newly found understanding of molecular control to develop specific and safe chemical, biological, and molecular regulators of TNFalpha for potential therapeutic use. Their effectiveness in controlling environmental or occupational diseases has yet to be established.


Subject(s)
Chemical and Drug Induced Liver Injury/metabolism , Chemical and Drug Induced Liver Injury/pathology , Inflammation/chemically induced , Liver/pathology , Tumor Necrosis Factor-alpha/metabolism , Animals , Carbon Tetrachloride/toxicity , Cell Division , Cells, Cultured , Gene Expression Regulation/drug effects , Liver/drug effects , Liver/metabolism , Mice , Mice, Inbred C57BL , Mice, Knockout , Necrosis , Proliferating Cell Nuclear Antigen/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism , Receptors, Tumor Necrosis Factor/genetics , Tumor Necrosis Factor-alpha/genetics , Tumor Necrosis Factor-alpha/immunology
5.
J Neurosci Res ; 62(1): 146-55, 2000 Oct 01.
Article in English | MEDLINE | ID: mdl-11002296

ABSTRACT

The osteopetrotic (op/op) mouse, deficient in biologically active colony stimulating factor 1 (CSF-1), was used to examine the role of microglia in chemical-induced trauma. Op/op mice and normal phenotype littermates (non-op/op) received an acute i.p. injection of the hippocampal toxicant, trimethyltin hydroxide (TMT; 1.5 or 2.0 mg/kg). At 2.0 mg/kg, both mice displayed severe degeneration of dentate granule neurons. At 1.5 mg/kg, non-op/op mice showed a limited punctate pattern of neuronal death while op/op mice showed prominent neuronal death. TMT-induced astrocyte reactivity was similar in both groups. RNase protection assays were conducted on hippocampal tissue at 24 hr post-TMT. Elevations were seen in mRNA levels for the host response genes: intercellular cell adhesion molecule (ICAM-1; non-op/op 80%, op/op 85%), the protease inhibitor EB22 (non-op/op 60%, op/op 300%), and glial fibrillary acidic protein (GFAP; non-op/op 300%, op/op 480%) within 24 hr. Macrophage-1 antigen (Mac-1) mRNA levels were lower in all op/op mice and were not induced by TMT exposure. Macrophage inflammatory protein (MIP)-1alpha and MIP-1beta mRNA levels were elevated in non-op/op mice while mRNA levels for interferon inducible protein (IP-10) and monocyte chemoattractant protein (MCP-1) were elevated in op/op mice. Tumor necrosis factor alpha (TNFalpha) mRNA levels were significantly elevated in both non-op/op (100%) and op/op (600%) mice. TNFbeta mRNA levels in op/op mice were elevated 200% and interleukin 1alpha (IL-1alpha) 150%. Reverse transcriptase polymerase chain reaction (RT-PCR) showed a TMT-induced elevation in INFalpha and INFbeta mRNA levels and no elevation of INFgamma. mRNA levels of the CSF-1 receptor, c-fms, were unaltered.


Subject(s)
Cytokines/chemistry , Hippocampus/metabolism , Microglia/metabolism , Neurodegenerative Diseases/metabolism , Osteopetrosis/metabolism , RNA, Messenger/metabolism , Animals , Astrocytes/drug effects , Astrocytes/metabolism , Astrocytes/pathology , Cell Survival/drug effects , Chemokine CCL2/genetics , Chemokine CCL2/metabolism , Chemokine CXCL10 , Chemokines, CXC/genetics , Chemokines, CXC/metabolism , Dose-Response Relationship, Drug , Female , Glial Fibrillary Acidic Protein/metabolism , Hippocampus/drug effects , Hippocampus/pathology , Intercellular Adhesion Molecule-1/genetics , Intercellular Adhesion Molecule-1/metabolism , Interleukin-1/genetics , Interleukin-1/metabolism , Lymphotoxin-alpha/genetics , Lymphotoxin-alpha/metabolism , Male , Mice , Mice, Mutant Strains , Neurodegenerative Diseases/chemically induced , Neurodegenerative Diseases/complications , Neurodegenerative Diseases/pathology , Neurons/drug effects , Neurons/pathology , Osteopetrosis/complications , Osteopetrosis/genetics , Receptor, Macrophage Colony-Stimulating Factor/genetics , Receptor, Macrophage Colony-Stimulating Factor/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Ribonucleases/metabolism , Trimethyltin Compounds , Tumor Necrosis Factor-alpha/genetics , Tumor Necrosis Factor-alpha/metabolism
6.
Radiat Res ; 153(5 Pt 2): 642-7, 2000 May.
Article in English | MEDLINE | ID: mdl-10790287

ABSTRACT

Fischer 344 rats were exposed to 60 Hz magnetic fields (EMFs) during gestation and lactation. Rats received continuous exposure to 2-, 200- or 1000-microT magnetic fields for 18.5 h per day, 7 days a week, or sham exposure (sham controls). During postnatal development, on postnatal days 1, 3, 6, 9, 15 and 20, forebrain tissue from male pups was examined for alterations in mRNA level for developmentally regulated central nervous system-specific proteins. Alterations in these factors during critical periods of development could result in alterations in the final neural network. Gap43 (growth-associated protein 43) mRNA was measured by Northern hybridization as a developmental indicator of axonal growth during the development of the neuron. Between postnatal days 1 and 9, detectable levels of Gap43 mRNA displayed a similar pattern across all sham control and exposure groups. In addition to Gap43, mRNA levels for the nervous system-specific growth factors ciliary neurotrophic factor (Cntf), brain-derived neurotrophic factor (Bdnf), beta nerve growth factor (Ngfb), neurotrophin-3 (Ntf3), and neurotrophin-4 (Ntf4) were examined by RNase protection assay. While there is public concern for developmental neurotoxicity associated with exposure to EMFs, these data, generated from animals exposed to 2-, 200- or 1000-microT magnetic fields during both gestational and lactational periods of development, suggest that under these conditions no significant alterations in these critical factors for brain development occur.


Subject(s)
Electromagnetic Fields/adverse effects , Environmental Exposure/adverse effects , GAP-43 Protein/metabolism , Maternal Exposure/adverse effects , Prosencephalon/radiation effects , Animals , Animals, Newborn , Animals, Suckling , Brain-Derived Neurotrophic Factor/genetics , Brain-Derived Neurotrophic Factor/metabolism , Dose-Response Relationship, Radiation , Female , GAP-43 Protein/genetics , Glial Cell Line-Derived Neurotrophic Factor , Male , Nerve Growth Factor/genetics , Nerve Growth Factor/metabolism , Nerve Growth Factors/genetics , Nerve Growth Factors/metabolism , Nerve Tissue Proteins/genetics , Nerve Tissue Proteins/metabolism , Neurotrophin 3/genetics , Neurotrophin 3/metabolism , Prosencephalon/growth & development , Prosencephalon/metabolism , RNA, Messenger/analysis , Rats , Rats, Inbred F344 , Rats, Sprague-Dawley , Ribonucleases/metabolism
7.
Infect Immun ; 68(3): 1724-6, 2000 Mar.
Article in English | MEDLINE | ID: mdl-10678997

ABSTRACT

Killing of intracellular Penicillium marneffei conidia is demonstrated in gamma interferon-lipopolysaccharide-activated human THP1 and mouse J774 cells. Iron overload significantly reduces the antifungal activity of macrophages. Likewise, exogenous iron enhances and iron chelators inhibit the extracellular growth of P. marneffei. These results suggest that iron availability critically affects immunity to and the pathogenicity of P. marneffei.


Subject(s)
Iron/pharmacology , Penicillium/drug effects , Animals , Deferoxamine/pharmacology , Humans , Interferon-gamma/pharmacology , Iron Overload/microbiology , Lipopolysaccharides/pharmacology , Mice , Nitric Oxide/physiology , Penicillium/growth & development
8.
J Neurosci Res ; 57(6): 916-26, 1999 Sep 15.
Article in English | MEDLINE | ID: mdl-10467263

ABSTRACT

An acute administration of the hippocampal toxicant trimethyltin (TMT) produced a specific pattern of neuronal necrosis in dentate granule cells with accompanying astrogliosis and initiation of a cytokine response within 24 hours. The purpose of this study was to examine the effects of the anti-inflammatory agent, dexamethasone (DEX), on the pattern of cytokine expression and neuronal degeneration occurring after an acute TMT injection. Dexamethasone (0.2 mg/kg or 10 mg/kg) was administered to 21-day-old male mice 1 hour prior to an injection of TMT hydroxide (2.5 mg/kg, i.p.). Mice receiving 0.2 mg/kg DEX received a second injection 6 hours after TMT. Twenty-four hours later, neuronal necrosis and astrogliosis were assessed and found to be similar in animals treated with TMT, either in the presence or absence of dexamethasone. Pretreatment with dexamethasone failed to prevent the neurodegeneration and astrogliosis. The TMT-induced injury response was represented in elevations of mRNA levels for the injury-associated host response genes glial fibrillary acidic protein (GFAP), EB22/5.3, and intercellular adhesion molecule-1 (ICAM-1). The combination of DEX and TMT produced increased elevation in mRNA levels for EB22/5.3 and ICAM, while GFAP levels remained the same as with TMT alone. The injury response from TMT was accompanied by elevations in mRNA levels for the cytokines tumor necrosis factor (TNF) alpha, TNFbeta, and interleukin (IL)-1alpha. Treatment with dexamethasone prior to TMT resulted in significantly elevated levels of TNFalpha, TNFbeta, and IL-1alpha as compared to TMT alone. These data represent the inability of glucocorticoids to downregulate the injury response in rat hippocampus following a systemic injection of TMT and suggest a stimulation and "priming" of hippocampal cells by dexamethasone.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Cytokines/genetics , Dexamethasone/pharmacology , Hippocampus/drug effects , Nerve Degeneration , RNA, Messenger/metabolism , Analysis of Variance , Animals , Gliosis/chemically induced , Gliosis/metabolism , Gliosis/pathology , Hippocampus/metabolism , Hippocampus/pathology , Male , Mice , Mice, Inbred Strains , Necrosis , Neurotoxins/toxicity , Ribonucleases , Transcription Factor AP-1/metabolism , Trimethyltin Compounds/toxicity
9.
Am J Pathol ; 153(6): 1775-85, 1998 Dec.
Article in English | MEDLINE | ID: mdl-9846968

ABSTRACT

Although numerous epidemiological studies have shown that inorganic arsenicals cause skin cancers and hyperkeratoses in humans, there are currently no established mechanisms for their action or animal models. Previous studies in our laboratory using primary human keratinocyte cultures demonstrated that micromolar concentrations of inorganic arsenite increased cell proliferation via the production of keratinocyte-derived growth factors. As recent reports demonstrate that overexpression of keratinocyte-derived growth factors, such as transforming growth factor (TGF)-alpha, promote the formation of skin tumors, we hypothesized that similar events may be responsible for those associated with arsenic skin diseases. Thus, the influence of arsenic in humans with arsenic skin disease and on mouse skin tumor development in transgenic mice was studied. After low-dose application of tetradecanoyl phorbol acetate (TPA), a marked increase in the number of skin papillomas occurred in Tg.AC mice, which carry the v-Ha-ras oncogene, that received arsenic in the drinking water as compared with control drinking water, whereas no papillomas developed in arsenic-treated transgenic mice that did not receive TPA or arsenic/TPA-treated wild-type FVB/N mice. Consistent with earlier in vitro findings, increases in granulocyte/macrophage colony-stimulating factor (GM-CSF) and TGF-alpha mRNA transcripts were found in the epidermis at clinically normal sites within 10 weeks after arsenic treatment. Immunohistochemical staining localized TGF-alpha overexpression to the hair follicles. Injection of neutralizing antibodies to GM-CSF after TPA application reduced the number of papillomas in Tg.AC mice. Analysis of gene expression in samples of skin lesions obtained from humans chronically exposed to arsenic via their drinking water also showed similar alterations in growth factor expression. Although confirmation will be required in nontransgenic mice, these results suggest that arsenic enhances development of skin neoplasias via the chronic stimulation of keratinocyte-derived growth factors and may be a rare example of a chemical carcinogen that acts as a co-promoter.


Subject(s)
Arsenic/toxicity , Growth Substances/metabolism , Skin Neoplasms/chemically induced , Animals , Antibodies/pharmacology , Arsenic/administration & dosage , Arsenic/analysis , Cell Division , Female , Granulocyte-Macrophage Colony-Stimulating Factor/immunology , Granulocyte-Macrophage Colony-Stimulating Factor/metabolism , Growth Substances/immunology , Humans , Immunohistochemistry , Mice , Mice, Transgenic , Papilloma/chemically induced , Papilloma/immunology , RNA, Messenger/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Skin Diseases/chemically induced , Skin Diseases/immunology , Skin Neoplasms/metabolism , Tetradecanoylphorbol Acetate/administration & dosage , Tissue Distribution , Transforming Growth Factor alpha/immunology , Transforming Growth Factor alpha/metabolism
10.
J Neurochem ; 71(4): 1577-87, 1998 Oct.
Article in English | MEDLINE | ID: mdl-9751191

ABSTRACT

In certain pathologic states, cytokine production may become spatially and temporally dysregulated, leading to their inappropriate production and potentially detrimental consequences. Tumor necrosis factor-alpha (TNF-alpha), interleukin (IL)-1, IL-6, and transforming growth factor-beta (TGF-beta) mediate a range of host responses affecting multiple cell types. To study the role of cytokines in the early stages of brain injury, we examined alterations in the 17-day-old mouse hippocampus during trimethyltin-induced neurodegeneration characterized by neuronal necrosis, microglia activation in the dentate, and astrocyte reactivity throughout the hippocampus. By 24 h after dosing, elevations in mRNA levels for TNF-alpha, IL-1alpha, IL-1beta, and IL-6 mRNA were seen. TGF-beta1 mRNA was elevated at 72 h. In situ hybridization showed that TNF-alpha and IL-1alpha were localized to the microglia, whereas TGF-beta1 was expressed predominantly in hippocampal pyramidal cells. Intercellular adhesion molecule-1, EB-22, Mac-1, and glial fibrillary acidic protein mRNA levels were elevated within the first 3 days of exposure in the absence of increased inducible nitric oxide synthetase and interferon-gamma mRNA. These data suggest that pro-inflammatory cytokines contribute to the progression and pattern of neuronal degeneration in the hippocampus.


Subject(s)
Hippocampus/metabolism , Interleukin-1/metabolism , RNA, Messenger/metabolism , Transforming Growth Factor beta/metabolism , Trimethyltin Compounds/toxicity , Tumor Necrosis Factor-alpha/metabolism , Animals , Hippocampus/drug effects , Hippocampus/pathology , Immunohistochemistry , In Situ Hybridization , Interleukin-1/genetics , Male , Mice , Ribonucleases/metabolism , Synaptophysin/analysis , Time Factors , Transforming Growth Factor beta/genetics , Tumor Necrosis Factor-alpha/genetics
11.
J Neuroimmunol ; 88(1-2): 154-64, 1998 Aug 01.
Article in English | MEDLINE | ID: mdl-9688337

ABSTRACT

This study examined the early response of pro-inflammatory and regulatory cytokines in the mouse brain following triethyltin (TET)-induced myelin injury characterized by edematous vacuolation. Following an acute intraperitoneal injection of triethyltin (TET) sulfate (3 mg/kg) to 17-day old CD1 mice, significant increases in brain stem TNF-alpha and IL-1alpha mRNA levels occurred at 6 and 24 h, respectively with elevations in TGF-beta1 and MIP-1alpha at 1 h. In the cortex, responses were limited to elevations at 6 h in TNF-alpha, TGF-beta1 and MIP-1alpha. These data suggest that a chemokine/cytokine response can occur with minimal alterations to the integrity of the myelin sheath and may contribute to the initial signaling mechanisms associated with demyelinating disorders.


Subject(s)
Brain Edema/metabolism , Brain Stem/metabolism , Cytokines/genetics , Myelin Sheath/metabolism , RNA, Messenger/metabolism , Animals , Brain Edema/chemically induced , Brain Edema/pathology , Brain Stem/drug effects , Chemokine CCL3 , Chemokine CCL4 , In Situ Hybridization , Macrophage Inflammatory Proteins/genetics , Male , Mice , Mice, Inbred Strains , Microscopy, Electron , Myelin Sheath/drug effects , Myelin Sheath/pathology , Ribonucleases , Transforming Growth Factor beta/genetics , Triethyltin Compounds/pharmacology
12.
J Invest Dermatol ; 108(6): 892-6, 1997 Jun.
Article in English | MEDLINE | ID: mdl-9182817

ABSTRACT

Skin irritant reactions are under the control of a network of cytokines and lipid mediators. This study characterized the production of tumor necrosis factor-alpha (TNF) induced by a skin irritant treatment, tributyltin (TBT), in mice through transcription factor activation and its pharmacologic modulation by anti-inflammatory agents. The ears of BALB/c mice were painted with different amounts of TBT (67-536 nmol in acetone) or with acetone alone. At different times thereafter, TNF production was analyzed both at the mRNA and protein level, by semiquantitative RT-PCR and L929 cytotoxicity assay, respectively. TBT induced rapid (1 h) TNF gene expression and protein synthesis. Maximal TNF production was observed 2 h after treatment. The production of TNF was paralleled by accumulation of skin water; this was partially prevented by intraperitoneal injection of antibody against murine TNF. These data indicate that skin irritation induced by TBT is attributable, in addition to the actions of other inflammatory mediators, to the action of keratinocyte-derived TNF. TNF production was preceded by a rapid (5 min) activation of nuclear factor-kappaB (NF-kappaB), which was also maximal 30 min after treatment. TBT-induced accumulation of skin water and TNF production were significantly reduced by topical treatment with dexamethasone and pentamidine, two anti-inflammatory agents. Interestingly, dexamethasone, but not pentamidine, decreased TBT-induced NF-kappaB activation, confirming in vivo that the glucocorticoid receptor interacts functionally within the nucleus with other transcription factors opposing one another's activity.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Gene Expression Regulation/drug effects , Irritants/pharmacology , Skin/drug effects , Transcription Factors/physiology , Trialkyltin Compounds/pharmacology , Tumor Necrosis Factor-alpha/genetics , Animals , Base Sequence , DNA/analysis , DNA/chemistry , DNA/genetics , Dexamethasone/pharmacology , Dose-Response Relationship, Drug , Enzyme-Linked Immunosorbent Assay , Female , Gene Expression Regulation/physiology , Mice , Mice, Inbred BALB C , NF-kappa B/physiology , Pentamidine/pharmacology , Polymerase Chain Reaction , RNA, Messenger/analysis , RNA, Messenger/genetics , RNA, Messenger/metabolism , Skin/chemistry , Skin/metabolism , Time Factors , Tumor Necrosis Factor-alpha/analysis , Tumor Necrosis Factor-alpha/metabolism
13.
Mutat Res ; 386(3): 209-18, 1997 Jun.
Article in English | MEDLINE | ID: mdl-9219559

ABSTRACT

Although numerous epidemiological studies have shown that inorganic arsenicals are human skin carcinogens, there is currently no accepted mechanism for its action or an established animal model for its study. We observed increased mRNA transcripts and secretion of keratinocyte growth factors, including granulocyte macrophage-colony stimulating factor (GM-CSF) and transforming growth factor-alpha (TGF-alpha) and the proinflammatory cytokine tumor necrosis factor-alpha (TNF-alpha) in primary human epidermal keratinocytes cultured in the presence of low micromolar concentrations of sodium arsenite. Total cell numbers, as well as c-myc expression and incorporation of [3H]thymidine, both indicators of cell proliferation, were also elevated in keratinocyte cultures treated with sodium arsenite. As an in vivo model, the influence of arsenic on mouse skin tumor development was studied in transgenic TG.AC mice which carry the v-Ha-ras oncogene, and can serve as a genetically initiated model for skin carcinogenesis. Following low-dose application of 12-O-tetradecanoyl phorbol-13-acetate (TPA), a marked increase in the number of skin papillomas occurred in transgenic mice receiving arsenic in the drinking water as compared to control drinking water. Papillomas did not develop in arsenic-treated transgenic mice that had not received TPA or arsenic-treated wild-type FVB/N mice, suggesting that arsenic is neither a tumor initiator or promoter but rather an enhancer. Injection of anti-GM-CSF antibodies following application of TPA in transgenic mice reduced the number of papillomas. Consistent with that observed in human keratinocyte cultures, increases in GM-CSF and TGF-alpha mRNA transcripts were found within the epidermis of arsenic-treated mice when compared to controls within 6 weeks of treatment. These results suggest that arsenic enhances papilloma development via the chronic stimulation of keratinocyte-derived growth factors and represents the first example of a chemical carcinogen that acts in this manner. These studies suggest that in vitro studies with human keratinocyte cultures examined in conjunction with TG.AC transgenic mice can provide a useful model for examining the tumor enhancing properties of environmental chemicals.


Subject(s)
Arsenic/toxicity , Granulocyte-Macrophage Colony-Stimulating Factor/biosynthesis , Keratinocytes/pathology , Skin Neoplasms/etiology , Transforming Growth Factor alpha/biosynthesis , Tumor Necrosis Factor-alpha/biosynthesis , Animals , Environmental Pollutants/toxicity , Female , Humans , Keratinocytes/drug effects , Keratinocytes/metabolism , Mice , Skin Neoplasms/pathology
14.
Carcinogenesis ; 18(4): 669-74, 1997 Apr.
Article in English | MEDLINE | ID: mdl-9111198

ABSTRACT

Several structurally dissimilar hypolipidemic drugs, plasticizers and halogenated hydrocarbons induce peroxisomes in hepatocytes, and cause hepatocellular adenoma and carcinoma in rats and mice. The mechanism by which these agents act is unknown, although recent studies have suggested a link between increased cell proliferation and hepatic cancer caused by peroxisome proliferators. Here, we demonstrate that neutralizing antibodies to tumor necrosis factor alpha (TNF alpha) block increases in protein kinase C and cell proliferation due to [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (WY-14,643), a hypolipidemic drug and potent peroxisome proliferator that causes tumors. WY-14,643 moderately elevated the level of TNF alpha mRNA in the liver. TNF alpha was detected immunohistochemically exclusively in Kupffer cells. These results demonstrate that WY-14,643 acts as an indirect mitogen on hepatocytes via TNF alpha. We propose that the Kupffer cell, a major source of TNF alpha in the liver, is involved in the mechanism of the mitogenic effect of WY-14,643.


Subject(s)
Antibodies/pharmacology , Liver/drug effects , Microbodies/drug effects , Pyrimidines/pharmacology , Tumor Necrosis Factor-alpha/immunology , Animals , Cell Division/drug effects , Cell Division/immunology , Liver/cytology , Male , Mitogens/pharmacology , Rats , Rats, Inbred F344
15.
Hepatology ; 25(1): 133-41, 1997 Jan.
Article in English | MEDLINE | ID: mdl-8985279

ABSTRACT

We and others have shown that tumor necrosis factor alpha (TNF-alpha) expression is increased in the livers of experimental animals following exposure to the chemical hepatotoxin, carbon tetrachloride (CCl4). Because TNF-alpha is involved in mediating inflammatory responses, its elevated expression is presumed to be associated with potentiating hepatotoxicity and/or aiding in liver repair processes. To study the role of TNF-alpha in chemical-induced hepatotoxicity, mice were administered neutralizing antibodies to TNF-alpha before administration of low, but hepatotoxic, doses of CCl4. Antibody treatment prevented CCl4-mediated increases in early-immediate gene expression associated with liver regeneration, including expression of c-jun and c-fos proto-oncogenes, as well as DNA binding of the activator protein-1 (AP-1) nuclear transcription factor. Hepatocyte proliferation following CCl4 treatment was also reduced in anti-TNF-alpha antibody-treated mice, as evidenced by a lack of proliferating cell nuclear antigen (PCNA) staining. Antibody treatment slightly delayed liver repair processes, as evidenced by extending the period in which plasma liver enzyme levels were increased and hepatocellular necrosis could be observed. Consistent with the above observations, injection of recombinant TNF-alpha into control mice induced rapid expression of c-jun and c-fos proto-oncogenes. Taken together, these results indicate that TNF-alpha positively modulates liver recovery following CCl4 exposure presumably by stimulating early-immediate genes involved in hepatic mitogenesis, a phenomenon also observed following partial hepatectomy.


Subject(s)
Gene Expression Regulation , Genes, Immediate-Early , Liver/drug effects , Tumor Necrosis Factor-alpha/physiology , Animals , Carbon Tetrachloride/toxicity , DNA/metabolism , Female , Mice , Mice, Inbred C3H , Mice, Inbred C57BL , Proliferating Cell Nuclear Antigen/analysis , Proto-Oncogenes , Rabbits , Transcription Factor AP-1/metabolism
16.
Res Commun Mol Pathol Pharmacol ; 92(3): 259-73, 1996 Jun.
Article in English | MEDLINE | ID: mdl-8827825

ABSTRACT

The AP-1 transcription factor family, which is involved in early response genes, consists of two groups of proteins, Fos-related antigens (fra) and Jun proteins. AP-1 is usually expressed at low basal cellular levels, but can be up-regulated by a variety of exogenous stimuli which results in synthesis of Fos and Jun proteins and increased AP-1 DNA binding activity. Changes in early immediate gene responses are associated with liver necrosis, inflammation and repair, although investigations into their role in drug-induced hepatotoxicity have not been actively examined. In the present studies, we determined that exposure to necrogenic doses of acetaminophen (APAP) was associated with increased AP-1 DNA binding activity in mouse liver. The APAP-induced hepatic AP-1 DNA binding complex had affinity for both the consensus AP-1 and CRE sequences. Furthermore, c-jun, but not c-fos, mRNA transcripts were transiently increased following exposure to hepatotoxic doses of APAP. When endotoxin was administered to mice in order to elicit a hepatic inflammatory response without necrosis, increases in c-jun expression occurred without accompanying changes in AP-1 activity, indicating a different mechanism of action. When compared to conventional indicators of hepatotoxicity, such as plasma levels of liver-associated enzymes, changes in gene expression occurred much earlier and, at least with AP-1 activity, remained activated following normalization of liver enzyme levels. These studies suggest that the AP-1 transcription factor and associated genes are associated in the hepatotoxic response of liver to APAP and may serve as useful molecular biomarkers for chemical-induced hepatotoxicity.


Subject(s)
Acetaminophen/toxicity , Chemical and Drug Induced Liver Injury/etiology , DNA/metabolism , Gene Expression Regulation/drug effects , Genes, fos/drug effects , Genes, jun/drug effects , Transcription Factor AP-1/metabolism , Transcription, Genetic/drug effects , Animals , Chemical and Drug Induced Liver Injury/genetics , Dimerization , Female , Liver/drug effects , Liver/pathology , Mice , Mice, Inbred C3H , Mice, Inbred C57BL , Necrosis , Protein Binding , Transcription Factor AP-1/chemistry , Transcription Factor AP-1/genetics
17.
Toxicol Appl Pharmacol ; 138(2): 268-74, 1996 Jun.
Article in English | MEDLINE | ID: mdl-8658528

ABSTRACT

Tributyltin (TBT) salts are well-known skin irritants in both human and rodents. This study investigated the role of interleukin-1alpha (IL-1alpha) in the process in mice and in murine keratinocytes. The ears of Balb/c mice were painted with different amounts of TBT (67-536 nmol in acetone) or with acetone alone. Two hours later there was dose-related production of IL-1alpha along with ear swelling and accumulation of skin water, all of which were partially prevented by intraperitoneal injection of antibody against murine IL-1alpha. By reverse transcription-polymerase chain reaction we were able to show that the neutralizing antibody also partially prevented TBT-induced in vivo IL-6 expression but no TBT-induced TNF-alpha expression, suggesting a paracrine effect of IL-1alpha on IL-6 production but not TNF-alpha expression and indicating that other inflammatory mediators are involved. TBT induced both intracellular production of IL-1alpha and its release into culture medium in a murine keratinocyte cell line (HEL30). IL-1alpha production was inhibited by addition of a neutralizing antibody against IL-1alpha, which suggests an autocrine effect of IL-1alpha on its own production. The intracellular production of IL-1alpha could he significantly inhibited by prior treatment with antioxidants, which strongly suggests a role for oxidative species in the mechanism of action of TBT in IL-1alpha induction. The complex-1 inhibitor rotenone also significantly inhibits IL-1alpha production. Since TBT causes disturbances in the respiratory chain in mitochondria, the mechanism of its action may be the production of reactive oxygen intermediates at the ubiquinone site, which activate transcription factors and promote IL-1alpha synthesis.


Subject(s)
Interleukin-1/adverse effects , Irritants/toxicity , Skin/drug effects , Trialkyltin Compounds/toxicity , Animals , Dermatitis, Contact/etiology , Female , Interleukin-1/biosynthesis , Interleukin-1/physiology , Keratinocytes/drug effects , Keratinocytes/metabolism , Mice , Mice, Inbred BALB C , Oxidation-Reduction/drug effects
18.
Toxicol Lett ; 82-83: 471-6, 1995 Dec.
Article in English | MEDLINE | ID: mdl-8597097

ABSTRACT

Following appropriate stimulation, such as with tumor promoters, ultraviolet light or various chemical agents, keratinocytes synthesize and secrete cytokines which can mediate or participate in dermatotoxic responses such as inflammation, hyperkeratosis, hypersensitivity and skin cancer. We have determined the qualitative and quantitative cytokine response in primary human keratinocyte cultures following exposure to several non-sensitizing contact irritants, sensitizers and ulcerative agents as well as a skin carcinogen. The chemicals were also administered to mice to assess whether the dermatotoxic response correlated with the in vitro production of keratinocyte-derived cytokines. Due to the complex cellular interactions that occur in the skin, it was not possible to identify specific cytokine profiles for most of the classes of dermatotoxic agents studied. However, the non-sensitizing contact irritants produced relative increases in the synthesis and secretion of the proinflammatory cytokines, interleukin-1 and tumor necrosis factor-alpha, as well as the neutrophil chemotactic cytokine, interleukin-8 compared to the other chemical agents. While ulcerative compounds as well as irritants elicited neutrophils to the site of chemical application when applied to the mouse skin, time-dependent and chemical-specific patterns of inflammation were detected. Treatment of human keratinocyte cultures with arsenic, a human skin carcinogen, resulted in a unique cytokine profile characterized by induction of growth factors, including transforming growth factor-alpha and granulocyte-macrophage colony stimulating factor. Treatment of v-Ha-ras transgenic mice, an animal model for skin cancer, with arsenic caused an increase in the number of papillomas as well as overexpression of these growth factors suggesting that they participate in arsenic-induced skin papilloma development. These studies indicate a diverse role exists for keratinocyte-derived cytokines in dermatotoxic actions.


Subject(s)
Cytokines/physiology , Keratinocytes/drug effects , Animals , Arsenic/toxicity , Cells, Cultured , Female , Humans , Keratinocytes/immunology , Mice , Mice, Inbred BALB C , Mice, Transgenic , Skin Neoplasms/chemically induced
19.
Photodermatol Photoimmunol Photomed ; 11(3): 112-8, 1995 Jun.
Article in English | MEDLINE | ID: mdl-8555009

ABSTRACT

It has been demonstrated that ultraviolet (UV) irradiation is able to induce both in vivo and in vitro, tumor necrosis factor-alpha (TNF) release. The purpose of the present study was to evaluate, using a human keratinocyte cell line NCTC 2544, the mechanism(s) of UV-induced TNF release and the ability of commonly used sunscreens to modulate UV-induced TNF release. TNF release can be partially prevented both by adding an anti-human IL-1 alpha antibody after irradiation, suggesting an autocrine effect of IL-1 alpha in inducing TNF release, and by adding antioxidants indicating also a role of oxidant species. TPCK, a I kappa-B alpha protease inhibitor, was able to virtually abolish UV-induced TNF release, indicating that UV-induced TNF release requires NF-kappa B activation. Anti-human IL-1 beta antibody was ineffective as expected, considering that keratinocytes are unable to process pre-IL-1 beta to its active form. To evaluate the sunscreen's modulation on UV-induced TNF release, confluent cells were irradiated, in the presence or absence of the tested sunscreens (Uvinul MS40, Uvinul P25 and Uvinul DS49). Different IC50 values could be calculated, which may be related to different UV absorption spectrums: Uvinul MS40 offers great protection by virtue of its broader absorption spectrum, closely followed by Uvinul P25 and finally by Uvinul DS49.


Subject(s)
Keratinocytes/radiation effects , Tumor Necrosis Factor-alpha/radiation effects , Ultraviolet Rays , 4-Aminobenzoic Acid/pharmacology , Antioxidants/pharmacology , Benzophenones/pharmacology , Cell Line , Cysteine/pharmacology , Humans , Interleukin-1/pharmacology , Keratinocytes/drug effects , Keratinocytes/metabolism , L-Lactate Dehydrogenase/metabolism , Oxidants/pharmacology , Proline/analogs & derivatives , Proline/pharmacology , Protein Synthesis Inhibitors/pharmacology , Reactive Oxygen Species/pharmacology , Serine Proteinase Inhibitors/pharmacology , Sulfonic Acids/pharmacology , Sunscreening Agents/pharmacology , Thiocarbamates/pharmacology , Tosylphenylalanyl Chloromethyl Ketone/pharmacology , Transcription Factors/pharmacology , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Tumor Necrosis Factor-alpha/metabolism , Ultraviolet Rays/classification
20.
J Inflamm ; 47(3): 138-50, 1995.
Article in English | MEDLINE | ID: mdl-9117441

ABSTRACT

Nuclear transcription factors, such as NF-kB and NF-IL6, are believed to play an important role in regulating the expression of genes that encode for products involved in tissue damage and inflammation and, thus, may represent early biomarkers for chemical toxicities. In the present study changes in DNA binding activity of these factors were examined in livers of mice administered hepatotoxic doses of acetaminophen (APAP). NF-kB and NF-IL6 DNA binding occurred constitutively in control mouse liver. However, within 4 hr following administration of hepatotoxic doses of APAP, their binding activities were transiently lost and is in contrast to AP-1 transcription factor where activation occurs under similar conditions. These changes corresponded with increased release of inflammatory mediators (IL-6, serum amyloid A) and increased levels of enzymatic markers of hepatocyte damage. Similarly, treatment of mice with gadolinium chloride, an inhibitor of Kupffer cell activation and known to protect against APAP-induced hepatotoxicity, reduced the observed pathophysiological response in the liver while altering the APAP-associated changes in NF-kB DNA binding activity. NF-kB was found predominantly in parenchymal and endothelial cells and was composed primarily of relatively inactive p50 homodimer subunits in control liver. Taken together, these studies suggest that hepatotoxicity is associated with early and complex changes in DNA binding activities of specific transcription factors. In particular, NF-kB and NF-IL6 may serve as negative regulators of hepatocyte-derived inflammatory mediators and is analogous to that previously observed in certain other cell systems such as B lymphocytes.


Subject(s)
Acetaminophen/toxicity , Analgesics, Non-Narcotic/toxicity , DNA-Binding Proteins/metabolism , DNA/metabolism , Liver/metabolism , NF-kappa B/metabolism , Nuclear Proteins/metabolism , Animals , Biomarkers , CCAAT-Enhancer-Binding Proteins , DNA-Binding Proteins/drug effects , DNA-Binding Proteins/genetics , Female , Gene Expression/drug effects , Immunohistochemistry , Liver/cytology , Liver/drug effects , Mice , Mice, Inbred C3H , Mice, Inbred C57BL , NF-kappa B/drug effects , NF-kappa B/genetics , Nuclear Proteins/drug effects , Nuclear Proteins/genetics , Oligonucleotide Probes/chemistry , Receptors, Cell Surface/drug effects , Receptors, Cell Surface/genetics , Receptors, Cell Surface/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...